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Introduction 
In 2010, the United Kingdom (UK) Government Department for International 
Development (DFID) announced their ‘Framework for results for reproductive, maternal and 
newborn health (RMNH)’ which included several ambitious goals in relation to reproductive, 
maternal and newborn health including saving 250,000 newborn and 50,000 maternal lives by 
2015 (1). DFID simultaneously committed to measuring its achievements in reaching these 
goals.   
DFID supports health progress in developing countries through a number of different aid 
modalities. These include direct budget support to the government (general funds or health 
funds), bilateral/multi-donor programs, regional programs, support to multilateral 
organizations (such as UNFPA and GAVI) and program partnership arrangements (PPA) with civil 
society organizations.  
Currently, there are no easy cost-effective methods available to directly measure the 
lives saved from the wide variety of types of health programs and funding streams. The most 
accurate method would be to directly measure mortality through before and after surveillance 
in the area where each individual program is implemented. However, this is time consuming, 
expensive and not feasible for all projects, especially those working at the national level or 
through budget support. There is also the possibility of double-counting the lives saved when 
programs overlap in place or time or over-ascribing impact to DFID programming when other 
programs exist in the area. In addition, measurement of maternal mortality at adequate 
precision to see statistically significant differences requires a very large population (100,000 or 
more pregnant women) that few programs reach.   
Alternatively, child mortality rates or maternal mortality ratios can be collected through 
existing national surveys. They are limited in that most priority countries will not have such 
surveys at the exact points in time (2010 and 2015) that are necessary to estimate these 
impacts for the DFID results framework. In addition, these surveys are unable to adequately 
identify DFID programming impacts separately from non-health and non-DFID activities.  
Selection of the modelling tool 
Given the limitations of the aforementioned direct measurement methods, modelling 
has the potential to estimate lives saved. Tools considered included the Lives Saved Tool 
(LiST)(2), UNICEF’s Marginal Budgeting for Bottlenecks (MBB)(3), the One Health Tool (OHT)(4), 
and the Marie Stopes International (MSI) Impact Calculator(5). These are discussed in turn, in 
relation to their potential benefits and limitations. An additional tool is available, called 
MANDATE, however this was not formally considered as its focus was intended to be on new 
technologies rather than existing ones(6). 
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LiST provides a structured format for users to combine the best scientific information 
about effectiveness of interventions for maternal, foetal, neonatal and child health with 
country specific information about cause of death and current coverage of interventions to 
inform their planning and decision-making as well as to help prioritize investments and evaluate 
existing programs(7). LiST utilizes publically available information on demography, family 
planning, HIV (incidence as well as preventions and treatments) and coverage of health 
interventions to estimate the number of lives saved by changes in these characteristics. It is 
built into the freely available Spectrum Policy Modelling Software(8), and has explicit linkages 
to Spectrum’s AIDS Impact (AIM) and Family Planning (FamPlan) modules(9). LiST is the result of 
more than 10 years of work by the Child Health Epidemiology Reference Group (CHERG) for 
WHO and UNICEF and collaborators, who have completed a series of systematic reviews with a 
consistent methodology (10) on the effectiveness of interventions that impact newborn and 
maternal (and child and foetal) mortality. This body of work became the basis for the 
development of a systematic way of combining current knowledge of effective interventions 
into a single package. The CHERG published their work in the Lancet Series on Child Mortality 
(2003)(11, 12), Neonatal Mortality (2005(13) and 2014(14)), Nutrition (2008(15) and 2013(16)), 
and Stillbirths (2011)(17, 18). In addition, there have been three supplements which included 
updates and additional data on effectiveness of interventions (IJE 2010, BMC Public Health 
2011, BMC Public Health 2013). Where the evidence of effectiveness of interventions was not 
available from robust epidemiological assessments, the CHERG applied the Delphi method – a 
formalized series of expert consultations – to generate an estimate of the required 
effectiveness parameters.  
MBB, the second modelling tool considered, uses a similar methodology to calculate the 
lives saved, and derived from the 2003 Child Survival Series, as did LiST. The effect sizes have 
not been formally updated, but MBB can use the newest LiST estimates if needed. It requires 
extensive information on delivery channels (e.g. outreach, community, clinic, hospital) and 
costs as well as health intervention coverage at these channels, in order to work well. MBB also 
requires a significant investment in time to accurately model individual programs rather than a 
comprehensive health system since it models health capacity as well as delivered interventions. 
Thus, MBB is ideal for systems level analyses rather than sub-system level. It is also located 
within an Excel spreadsheet, making it relatively easy to see all of the elements, but can also be 
perceived to be difficult to work through each of the steps due to its great size. 
The third option, OHT is based within the Spectrum software and uses LiST (and AIM and 
FamPlan) for the impact portion of its calculations. However, it has additional features, 
including costing and health systems, requiring significant additional inputs, similar to MBB. 
Again, it would require a significant investment of time to be able to do a single program 
analysis rather than the entire health system. In addition, this tool is somewhat less fully 
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developed than LiST or MBB, although it is already being used in countries and is supported by, 
and being developed by, the World Health Organization, among others.  
These three tools are similar in that each uses a combination of health interventions, 
effect sizes and underlying mortality to estimate lives saved. Each has a situation in which they 
are more appropriate. Both MBB and OHT have bottleneck analyses which are useful for 
planning purposes. If one is interested in the costs associated with the impacts, then either 
MBB or OHT would be more appropriate than LiST, although LiST does have the ability to look 
at marginal costs or specific intervention costs while excluding the costs of health system 
changes that might be needed. If evidence emerged that the effectiveness of interventions 
differed by level of care (e.g. community, clinic, hospital) then all three of these tools would 
need to be modified to improve their estimates of effectiveness.  
LiST is somewhat more nimble than MBB in that it primarily requires health intervention 
coverage, and does not require further disaggregation into the exact location of delivery (which 
may not be available). Nearly all of LiST’s effectiveness estimates have been updated since 2010 
(and can even be used as inputs to MBB if necessary, essentially updating the default 2003 
Child Survival Series effect sizes). Additionally, LiST is a quasi-cohort model, which allows for 
interactions between interventions. That means, if a child is saved from dying of a neonatal 
cause, then that child is not saved for the rest of that child’s life, but is at population risk of 
dying of other causes; the child that is saved has the same risk of dying of the later cause as all 
other children(19). This feature somewhat mimics the reality of life in which interventions 
delivered earlier in life can have unintended consequences. Another benefit of the quasi-cohort 
model within LiST is that it allows the model to include risks associated with nutritional 
deficiencies.  
The MSI Calculator is completely different and has a more comprehensive method of 
modelling impacts related to reproductive health. However, it is limited only to reproductive 
health interventions. It does not use effect sizes for calculating impact of interventions on 
mortality and other outcomes.  It instead uses correlations to calculate impact rather than 
directly modelling the causal pathways as used by the other software tools.  
No other tools have been identified which assess sector-wide mortality. Other tools 
have been developed by WHO (e.g.. CHOICE, et al.) which consider just costs, and not mortality, 
or just look at delivery care, but these are not currently in mainstream usage and were not 
considered. It should be noted that these tools are those which assess health impacts on 
mortality.  They do not assess or include estimates of non-health related inputs to mortality 
reduction, such as changes in socio-economic status, education of women, secular trends in 
mortality reduction. Also, there are currently no tools available which can model health systems 
strengthening interventions directly; rather they can model their outputs if they are known. 
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Table 1. Summary of major similarities and differences between the software tools considered.  
Topic 
Lives Saved Tool 
(LiST) 
Marginal Bottlenecks 
for Budgeting (MBB) 
One Health 
Tool (OHT) 
Marie Stopes 
Calculator (MSI) 
Method of 
estimating 
Lives Saved 
Interventions avert 
cause-specific 
mortality 
Interventions avert 
cause-specific 
mortality 
Interventions 
avert cause-
specific 
mortality 
Uses 
correlations of 
interventions 
with mortality 
Effect sizes Effect sizes updated 
regularly 
Primarily uses 2003 
effect sizes, or links 
directly to LiST 
Uses LiST 
directly 
Updated 
irregularly 
Model type Static quasi cohort 
model 
Static model  Quasi cohort 
model 
Static model  
Additional 
features/ 
limitations/ 
discussion 
points 
Has a separate 
costing module 
optional 
Excel based Uses 
additional 
health 
systems 
features 
Focuses only on 
reproductive 
health 
interventions 
 
After consulting with experts, DFID decided that the most appropriate choice for 
estimating its results on maternal and newborn lives saved was LiST. If additional tools become 
available before the end of the analysis period which afford the ability to look across the 
spectrum of health interventions, these will be considered for later comparative analyses.  
Use of modelling 
Modelling is a contentious tool within the global health monitoring and evaluation 
toolbox.  It does evade the aforementioned issues with direct data collection, but has its own 
critical limitations which must be considered, and will be discussed below.  Most importantly, 
modelling should not be allowed to replace critical thinking or to replace actual feasible data 
collection.  This use of modelling is responding to DFID’s two specific goals.  The first was to 
assess whether or not the funding being appropriated and delivered to global health issues was 
adequate to the task of reducing mortality as desired.  The second was to support DFID in 
identifying areas which could potentially benefit from additional DFID support.  
A general issue with attribution relates to the knowledge gap.  That is, not only are there 
multiple programs which co-exist, making attribution difficult, but there are multiple unknown 
programs which can affect health.  This is in addition to activities which are non-health related 
having an impact. These can include education, poverty, agriculture, infrastructure, etc.  There 
will also be unexplained synergies and antagonisms between all of these types of programs, as 
well as secular trends which, although they include the above issues, may also include many 
additional issues that are unknown and thus unquantifiable.  As a result, when any attribution is 
done, it inevitably will only refer to those activities which can be measured, which is only a 
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small subset of the reality. The theory under which LiST works is that many of these 
interventions and changes which cannot be modelled will be accounted for indirectly through 
the requirement that they eventually affect (albeit indirectly) interventions which can be 
modelled. 
As a direct result of these issues, (such as multiple partners, the knowledge gap, and 
additional related ideas) the results which will be discussed here should be termed as 
‘contributions’ rather than attributions. That is, the results which will be derived from this 
exercise do not reflect what DFID has actually done.  However, it does reflect what is likely that 
DFID has helped to support in the context of everything else that has occurred in the 
community and society.  Further expansion upon the limitations of these type of analyses are 
discussed at the end of this document.   
This technical note describes how DFID has chosen to use LiST to estimate lives saved 
from its bilateral health-related programs. The purpose of this note is to explain to internal 
DFID staff as well as external partners and the public the methodology used to support the 
calculations required by the Framework for results for RMNH and the limitations associated 
with it. It is aimed primarily at a specialist audience, and is one of three publications describing 
the methodology. An article for submission to an academic journal and a short overview for a 
non-specialist audience has also been prepared. The results will be published separately at the 
end of the project. Separate methodologies are being developed for including additional results 
from multi-country programs in countries where DFID does not have a bilateral health program. 
They are not described here, except in brief, since they have not yet been finalized.  
Methods 
Modelling maternal and newborn lives saved between 2011 and 2015 is undertaken 
annually using the most up-to-date version of the LiST software, and the latest program data 
from DFID country offices relating to health or family planning. The DFID focus countries were 
all invited to participate in this analysis, with 23 participating in the 2014–2015 analysis round, 
the third year of the analysis. For a list of the specific countries participating, by year, please see 
Appendix A. For a list of the Spectrum versions which were used in each round, please see 
Appendix B. Details of the health interventions which are modelled by LiST are available in 
Appendix C. 
Data on DFID attribution relating to each set of targets/achieved values are used to 
estimate what percentage of the program results are due to DFID funds when specific program 
data were not available. From these data, and the existing baseline data, two LiST projections 
were created (generally termed ‘observed‘ or ‘with DFID support’ and ‘hypothetical’ or ‘without 
DFID support’, to reflect what occurred with DFID funding and what might have occurred 
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without it), the difference between which was considered to be the impact of health and family 
planning supported by DFID. These were summed across all programs to get a national value, 
and then across all countries to get a global estimate. Additional analyses were created to 
exclude the impact of family planning. A flow chart of tasks is in Figure 1. Each stage is 
explained in detail below.  
Figure 1. Flow chart of major activities to generate maternal and neonatal lives saved for DFID 
 
Data Collection Methods 
Collect project data (DFID offices) 
A data collection spreadsheet was created by the analysis team in consultation with 
health and statistics advisers from DFID country offices. It required three main pieces of 
information: 1) the complete list of programs in each country relating to health or family 
planning delivered between 2010 and 2015, 2) the populations targeted or reached by each of 
the programs, and 3) the interventions (or inputs) delivered, and targets or achieved results, for 
each year.  
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The requirement for population data ensured that the analysts knew the size of the 
geographical area served by the program. It was also used if the program used population 
estimates for planning purposes which were not based upon the United Nations Population 
Division medium variant population projections. This was needed to correctly estimate the 
underlying population upon which any program would be acting, and would include 
information to also help predict the number of living children and the number of pregnancies. 
Depending on the program, the population information could be total population, total women, 
total pregnancies, etc.  
Country offices provided data on DFID attribution relating to each set of inputs, targets 
or achieved values. This enabled estimation of the percentage of program results which could 
be ascribed to DFID. 
Identify appropriate analysis populations 
Each project was assessed for three primary characteristics for a given calendar year: 
funding type (bilateral, multilateral…), geographic location (state/district/region within a 
country), and data available on the indicators. We then combined the individual projects’ 
information as appropriate into LiST analyses ensuring that we did not double count the 
coverage estimates or their impacts.  The exact combination of projects into analyses is 
available in each individual annual report, and can change from year to year, based upon how 
the data are reported.  
Funding Types 
DFID’s bilateral programs were analysed using LiST, including both general or health 
sector budget support and sole and multi-donor programs. Programs funded via other aid 
modalities were generally excluded to avoid the likelihood of double counting the benefits, 
although some multilateral programs were included in specific countries where it was certain 
that the same interventions were not already being modelled. For example, funds given to GAVI 
support vaccination, while funds given to a government may also be used to support 
vaccination. Both may be paying for a part of the same vaccinations and would result in an 
over-estimate of lives saved if both were modelled independently and added together. These 
types of programs are being analysed separately with a different methodology and are not 
being considered here directly. 
Combining data from individual programs into analyses 
Projects were considered to overlap under a variety of circumstances. They could 
overlap based on location, such as two programs working in the same defined area on different 
interventions, where combined modelling is required since the saving of lives from one set of 
interventions could affect the second set of interventions. In this scenario, multiple programs 
would be combined into a single analysis. Alternatively, two projects could overlap on both 
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intervention and area. For example, a budget support program may consider delivery of ITNs as 
part of their program, since they are distributed at ANC clinics. Another DFID program might be 
responsible for purchasing all of the nets nationally. If both projects were modelled together, 
then each net would be counted twice. In this case, the program which purchased the nets 
would get the credit, but not the budget support program. All other activities relating to ANC 
would be considered as part of the budget support program and only the ITNs would be 
excluded. 
Analysis generation 
Once all of the projects for a country had been assessed for funding type, temporal and 
regional overlap and intervention overlap, a list of the analyses to be performed was created. 
There could be either more or fewer analyses than programs. For example, there could be two 
budget support programs, which when combined resulted in one national analysis. 
Alternatively, one program could focus on two regions with different baseline and target values 
and different underlying epidemiology and mortality rates. In this case, there would be two 
analyses, one for each region. This was done to minimize the number of analyses needed while 
also increasing the quality of the underlying data being used. At the end, the number of 
projects and the number of analyses in each country was summarized. The year 3 summary is 
below in Table 2.  A key point to note is the drop-off between the projects reported and those 
analysed.  Many projects without appropriate indicators, and many that are health systems 
strengthening types of projects could not be modelled.  
Table 2. Comparison of data available for and included in the analysis 
 Countries Reporting (N) Analyses (N) Projects Analysed Projects Reported 
2010–2011 19 40 87 127 
2010–2012 20 (19)* 47 113 146 
2010–2013 23 53 146 178 
*One country reported but was unable to be analysed. 
For example, in one country, there were two projects in which ITN coverage was an 
indicator of interest. The coverage data being used by each project was the same (e.g. the 
national targets), while the geographic location was different (one national and one provincial). 
We would not analyse these two projects exactly as described since the assumption is that 
some of the bed nets mentioned in the provincial area are the same as those mentioned in the 
national program. The project would be split into one provincial analysis and one which covered 
the remainder of the country. This ensured that the provincial nets were not counted twice.  
Convert data into LiST coverage values 
The LiST model requires that data on each health intervention be in the format of a 
coverage value, ranging from 0% to 100%.  Thus, to be included, each analysis was converted 
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into a coverage value if not already reported as such for each calendar year of the analysis 
(2011–2015) as well as the baseline (2010) for insertion into a LiST projection.  
Baseline coverage data (2010) 
Whenever possible, project-specific data were used for baselines. Often countries 
reported their most recent national survey data. However in some cases, the underlying 
baseline data were not included; only the achieved/forecast values/targets might be available. 
In those cases, we used the best available data on coverage of health interventions to fill in the 
gaps. Typically, these came from Demographic and Health surveys (DHS) or Multiple Indicator 
Cluster Surveys (MICS). These surveys have data at both the national level as well as some sub-
national levels. For example, in Pakistan, there is quality data available at the provincial level. 
Whenever appropriate, we used the sub-national data for the analysis, although this was often 
not possible for very small scale programs. In addition, if there were two surveys, one prior to 
2010 and one after 2010, a linear interpolation between the values was used to generate the 
most likely 2010 estimate.  
Intervention data type  
 Two types of data were available for each health intervention: coverage or numbers 
delivered. Coverage refers to the percentage of the population in need that receive the health 
intervention. For example, 95% coverage of measles vaccine indicates that 95% of all children 
12–23 months of age have been vaccinated with measles vaccine. This was a common data type 
for budget support programs where the forecast values were actually national government 
targets of utilization. Coverage values were used directly as inputs into LiST. 
Numbers of health interventions delivered was also a typical coverage indicator. 
Numbers were converted into a coverage value for use in LiST by dividing the annual value by 
the underlying population. One example is for a program reporting that it delivered 3.2 million 
ITNs. The population in need of ITNs is households. Thus, the number of nets distributed was 
divided by the number of households to get the coverage value which could then be entered 
into LiST. If multiple programs reported their data in numbers, and these were clearly unique 
numbers, then the values were added together to generate the total number delivered prior to 
calculating the coverage by dividing by the underlying population in need. 
The underlying populations in need were generated from the default LiST projections 
when needed. The definition of population in need is the entire set of individuals who need an 
intervention, regardless of whether they are getting it currently or not. For example, the 
underlying population in need of a facility delivery is the number of births. There are default 
data within Spectrum which allow the projection of populations into the future based on the 
2012 UN Population Division projections. From these default projections, underlying 
populations can be obtained. These include the number of births, pregnancies, children under 
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5, women of reproductive age and total population, for use as potential denominators. The 
total population can be divided by the most recent DHS estimates of the household size to 
estimate the number of households. 
It was assumed that whenever supplies were reported as delivered, that they were 
actually received by beneficiaries.  This is a notable assumption since in some cases it is known 
that the supplied item never left the in-country warehouses. In addition, wastage is a common 
description of the percentage of a supply that does not get used. To correctly assess wastage, 
rates would be needed for each individual intervention, project and country. These 
assumptions related to supply risk overestimating lives saved in the modelled results.  
Not all programs included activities which could be modelled in LiST. Programs that 
reported only on knowledge shifts were typically not able to be included since there were no 
outcome data available. The exception was when handwashing or breastfeeding education 
programs were done and there was a known number of people reached. This was considered to 
be different than a program to improve the skills of a physician in a facility, with no clear 
explanation of the content, duration or impact of the program. Similarly, programs which only 
reported on adolescent impacts were also excluded. However, if adolescent programs reported 
on activities which could be modelled, such as family planning, then they were analysed 
although LiST does not automatically assume increased risk of maternal or neonatal mortality 
for adolescent mothers. If a program included at least one activity which could be modelled in 
LiST, it was included in the analysis. The effect of excluding certain activities is to risk 
underestimating lives saved. 
Specific interventions 
A list of all the interventions which were available in Spectrum 5.31, used at the time of 
the creation of this note, is available in Appendix C to this document. These are unlikely to 
change dramatically over time, while the effect sizes can vary from year to year as new data are 
available. In brief, the indicators which are included were identified as key in the Lancet Child 
Survival Series (2003), the Lancet Neonatal Series’ (2005, 2013), the Lancet Nutrition Series 
(2008, 2014) the Lancet Stillbirth Series (2011) as well as from supplements published in BMC 
Public Health and the International Journal of Epidemiology, and other published sources, if 
needed. Although the majority of the data are peer reviewed, the quality of the effect 
estimates varies; some estimates are from Delphi studies, while there is equipoise on several 
estimates and they are consequently modified relatively frequently as new information 
becomes available.  Several indicators required special consideration as described below. In all 
cases, if the values reported by the DFID country office were not reasonable for the ideal 
indicator and an alternative was available, the alternative was used and noted. 
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Insecticide treated bed nets (ITNs) 
It was assumed that any ITNs delivered would be effective for 3 years(20), the average 
duration of the insecticide. In addition, to calculate the underlying bednet coverage, we 
assumed that the existing stock would be phased out over three years. That is, that one third of 
the existing nets would be not useful after each of three years, which assumed that they had 
been delivered evenly over three years prior. This assumption is probably incorrect, but since 
this assumption would be relevant for both the ‘with DFID support and ‘without DFID support 
scenarios, the impact on deaths averted is negligible. We only used the ‘sleeping under an ITN’ 
indicator if the ‘ownership’ indicator was not available.  
Intermittent preventive treatment of malaria during pregnancy or sleeping under an 
ITN (IPTp) 
The ideal indicator is a composite indicator, where either IPTp (2 doses in pregnancy) or 
a pregnant woman sleeping under an ITN is considered protective. Unfortunately, this was 
rarely available as a standard value and it is typically incorrect to add the two together since 
they are often being used in tandem by pregnant women. Whenever the ideal indicator was not 
available, but both of the individual values were available, we chose to use the higher of the 
two as our baseline value. The effect of this assumption is to risk underestimating lives saved.  
In some countries, there were only data on the number of ITNs delivered to pregnant 
women. We added these additional nets to whichever appropriate baseline indicator was used. 
We used the same methods of decreasing coverage over three years, as described above, to 
estimate the duration of protection, although this risks overestimating lives saved because a 
woman is not continuously pregnant during that time period. 
Antenatal care 
The standard LiST indicator for antenatal care (ANC) is 4 or more visits to a health 
professional during pregnancy. Occasionally a non-standard 2 or more visit indicator was 
shared by the programs. In that case, we converted the 2+ indicator into a 4+ indicator, by 
assuming that the ratio between 2+ and 4+ was the unchanged from that seen in the most 
recent national survey. If there were no data on the 4+ indicator available in any situation, we 
simply used the 2+ indicator instead, which will result in a slight overestimate of the impact. 
This decision will be re-evaluated each year that the analysis is performed. 
Breastfeeding  
Typical indicators for breastfeeding programs do not match those within LiST since LiST 
attempts to match the risk of mortality by age groups and by levels of breastfeeding. Thus, 
programs often have an indicator of whether or not children less than 6 months of age are 
exclusively breastfeeding while LiST requires inputs for neonates separately from 1-5 month old 
children as well as for, in addition to exclusive breastfeeding, predominant, partial and no 
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breastfeeding. Each combination of age and breastfeeding type has a different mortality risk 
profile. Converting the available data into LiST coverage information is somewhat subjective. In 
reality although a single value is reported, it reflects the natural high initiation of breastfeeding 
and the reduction and dropouts over time to a lower value by the time the child is 6 months of 
age. Because of the natural history of this behaviour, when we applied the reported target to 
both age groups, frequently, the 0-1 month age group had already achieved the 0-6 month 
value. Thus, in these situations where the reported value for breastfeeding from 0-6 months of 
age is lower than the available data on neonatal breastfeeding rates, we could only apply the 
observed change to the children in the 1-5 month old category. The implications of that are that 
it is likely that in some countries, the impact of breastfeeding on neonatal mortality is being 
underestimated or completely ignored while the number of deaths averted in the 1-5 month 
category may be overestimated. Also, we had to determine which non-ideal category of 
breastfeeding was reduced as the exclusive was increased. This was done on a program-by-
program basis, based upon the type of data available.  If no data were available, we would 
assume the most conservative possible result, which was to assume that predominant 
breastfeeding was reduced and exclusive was increased.  See the help menus internal to LiST 
for further details of the breastfeeding calculations. 
Infrastructure 
Several programs related to infrastructure were also modelled. These included 
improved sanitation, improved water, and quality improvements related to facilities for 
childbirth. Whenever the intervention delivered was reported in terms of infrastructure built, 
we assumed that this was a fixed intervention which had impacts which continued and 
remained through the entire analysis period (2011–2015). Thus, if the data were in terms of 
population covered in a given year, we assumed that that population number (not the 
percentage) was also covered in subsequent years.  
Delivery care is notably complex. LiST makes assumptions about the proportion of 
facility deliveries which take place in very basic facilities, facilities that can theoretically perform 
all of the basic emergency obstetric and newborn care (BEmONC) functions and those that can 
theoretically perform all of the comprehensive emergency obstetric and newborn care 
(CEmONC) functions based upon the overall proportion of facility births (out of all births). These 
default assumptions are detailed in the LiST software help menus. One key assumption is that 
even facilities that are considered to be BEmONC or CEmONC do not always actually perform all 
of the expected signal functions. This assumption of sub-optimal quality is standard in LiST, and 
should be explored where evidence is available. Programs on childbirth care can vary greatly. 
Thus the modelling for these programs will also vary. One program might be a demand 
generation program, and the overall facility birth rate is increased. In that case, no adjustments 
to the proportions of types of facilities will be made, assuming that no changes in quality of 
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care will automatically occur. Another program might be upgrading existing facilities to 
BEmONC level quality (or upgrading all BEmONC-type facilities to actually provide all of the 
signal functions). In those situations, the overall percentage of facility births is not going to 
change. However, the quality (and in LiST, the type of facility or the specific interventions within 
the facility) will change. The decisions on exactly how to model this change in quality will 
depend on both the data as well as any additional information shared by the DFID country 
offices.  
Family planning 
The modelling of family planning occurs within the FamPlan module of Spectrum and 
not within LiST itself. Family planning must be considered for every single analysis since changes 
in family planning rates, or contraception, will affect the total fertility rate, with downstream 
effects on the number of births, pregnancies and ultimately the number of deaths and lives 
saved.  For countries in which there was no family planning activity, the underlying total fertility 
rate and thus family planning levels needed to be determined.  In countries with family 
planning activities, two questions needed to be assessed. The first was ‘how has the national 
contraceptive prevalence rate changed because of a program implementing family planning 
activities?’ The second was ‘how has the method mix, or proportion of modern/traditional 
methods, changed over time as a result of the program?’  
When family planning was part of a DFID country office program, contraceptive 
prevalence was obtained from of DFID’s twice yearly results return. Contraceptive prevalence 
rate forecast values were considered to be those which DFID supported, while the attribution 
reported was used to calculate the alternative contraceptive prevalence rate for modelling 
without DFID support. If contraceptive prevalence was not reported there, then values from the 
DFID country office data collection template were used. If neither was available, then the 
default values within Spectrum were used. The defaults within Spectrum are based upon the 
United Nations Population Division estimates and are assumed to increase as a result of a 
projected decrease in total fertility rates, in most countries. In these cases, we assumed that 
the values with and without DFID support were identical to ensure that we were not ascribing 
any benefit to DFID due to family planning when it was not being supported. 
For the first question when family planning activities were being implemented – how 
the contraceptive prevalence rate changed with a program that was implementing family 
planning – we assumed that all supplies reached the target beneficiaries, to be consistent with 
other supply driven intervention data that were reported by the countries. The effect of this 
assumption is to risk overestimating lives saved. 
For the second question – how the method mix changed over time – we had to consider 
how family planning is modelled in the software. Spectrum uses data from the most recent 
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DHS/MICS survey on contraceptive methods to define the method mix within a country. This 
includes both modern (e.g. condom, sterilization) and traditional (e.g. withdrawal) methods. 
However, DFID only supplies modern methods. Thus, if a country reported that they were 
delivering family planning supplies, we assumed that the increase was all in modern 
contraceptives, even if the reported indicator was all contraceptives. For a more general 
program, such as partnering with practitioners or community workers, then we assumed that 
there could be some increase in non-modern methods as well. 
It is important to note that, within LiST, since family planning has impacts on pregnancy 
rates, it will automatically impact both the number of maternal deaths (but not the mortality 
ratio) and the number of neonatal deaths (but not the neonatal mortality rate). For this 
analysis, only the impact of family planning on maternal mortality is considered.  See below for 
the explanation of how family planning changes were used to develop the underlying fertility 
rate for neonatal mortality calculations. 
Additional LiST data needed 
Additional data were needed by LiST for each of these analyses. These included 2010 
neonatal mortality rates (NMR), infant mortality rates (IMR), under-five mortality rates (U5MR) 
and maternal mortality ratios (MMR)  as well as stunting rates, wasting rates, diarrheal 
incidence rates etc., as described in Walker et al(7). For some information, such as mortality 
rates and ratios, there are multiple possible sources. A single source was chosen for consistency 
across all countries, regardless of additional data available. Additional sources for key values 
were varied in the sensitivity analyses described below. For mortality rates (NMR, IMR, U5MR), 
the most recent IGME estimate for the year 2010 was used as the baseline rate. For the 
maternal mortality ratio (MMR) we used the WHO 2010 estimates published in 2012.  
Analysis methods 
Create ‘with DFID support’ LiST projection 
Once all these data were compiled for each analysis, a LiST projection for the years 
2010–2015 was created for each analysis. Each LiST projection includes all of the underlying 
data described above as well as the projected number of births and deaths in each calendar 
year. This projection was typically required to begin in the year 1970 to ensure that the 2010–
2015 HIV data were correct, also explaining why the term ’projection’ is used for the analysis 
unit. Each analysis had a single ‘with DFID support projection. This projection was called the 
‘with DFID support’ scenario and was saved as the first part of the analysis.  
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Generate attribution values  
In order to estimate the lives saved over this time period, an alternative scenario, called 
‘without DFID support’, was needed. The difference between these two scenarios generates the 
final results. In order to calculate the ‘without DFID support’ scenario, each project and analysis 
needed to have the appropriate attribution calculated. The calculation method depended on 
the type of data, coverage percentage or numbers, and whether the attribution related to the 
total coverage or the additional coverage.  
In one example, the additional number of services (and thus an additional percent 
coverage) attributable to DFID funding and programming was available as described above in 
the coverage calculation estimates. It was assumed that DFID did not support the existing levels 
of coverage for that intervention, only the additional amount. If we assume that 100% of the 
additional amount was due to DFID funding, then the ‘without DFID support’ scenario assumed 
that there was no change in coverage from program baseline. Alternatively, if we assumed that 
only 50% of the services delivered were funded by DFID, then the ‘without DFID support’ 
scenario would have only half the coverage observed in the ‘with DFID support’ scenario. If 
multiple programs contributed, then the attribution was combined in the ‘without DFID 
support’ scenario (See Table 3).  
An alternative method was used when the program was assumed to contribute to total 
health output rather than to the additional health output. Typically this would be a proportion 
of the health budget paid for by DFID. In that case, the ‘with DFID support’ scenario reflects the 
total coverage of a health intervention in the population. The ‘without DFID support’ scenario is 
calculated by taking away the DFID funded proportion of the overall health output. See table 3 
below for examples.  
If multiple programs were contributing in varying amounts to the support of the total 
health system, then variable annual attributions could be calculated. For example, in some 
countries, there could be two budget support programs, i.e. a health budget program running 
from 2008–2013 and a general budget program running from 2012–2017. In the years 2012–
2013, the total attribution should be the sum of the two programs, while the year before (2011) 
would only include the attribution for the first program and the years after (2014–2015) would 
only include the attribution from the second program. Within each program, the annual 
attribution could be variable as well, depending on the data shared by the national office. 
Create ‘without DFID support’ LiST projection 
Once each of the attributions was defined, a second LiST projection was created for 
each of the initially created ‘with DFID support’ scenarios. It was critical that this was built on 
the exact existing projection and no changes were made to the year 2010 or earlier. This was 
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the only way to ensure that the 2010 values were identical in the ‘with DFID support’ and 
‘without DFID support’ projections and allow appropriate comparisons. 
Obtain MNCH+FP results (for maternal)  
At this point, the number of maternal deaths in each year in each of the two scenarios 
was generated. The difference between the two scenarios in each year was reported as the 
total maternal deaths averted. 
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Table 3. General Description of how different data types were modelled 
Data Type Additional Services Delivered by DFID 
(number)* 
Percentage of Total Health Budget 
Due to DFID‡ 
Data Needs Baseline Coverage, Services Delivered 
by DFID, Population  
Baseline Coverage, Final Coverage, % 
of total budget from DFID 
‘With DFID 
support’ 
Coverage 
Use Baseline and calculate % reached 
by services 
Use Baseline and Target Coverages 
‘With DFID 
support’ 
Example  
Baseline Coverage 50%  Baseline Coverage 50% 
Additional Services 
Delivered 
3,000   
Percent attributed 
to DFID 
40%   
Total Population in 
Need† 
10,000   
Calculation of 
additional 
coverage 
40%*3,000/ 
10,000=12% 
  
Final Coverage 50%+12%=62% Final Coverage 80% 
‘Without DFID 
support’ 
Description 
What would coverage be if the DFID supported services were not delivered 
 
‘Without DFID 
support’ 
Example 
Baseline Coverage 50% Baseline Coverage 50% 
Additional Services 
Delivered 
0 Percentage 
attributed to DFID 
50% 
Total Population in 
Need 
10,000 Final Coverage 80%-(50%*80%) 
=40% 
Final Coverage 50%+0%=50% 
Deaths Averted 
Calculation 
Deaths at 62% coverage minus Deaths 
at 50% coverage in the same year 
Deaths at 80% coverage minus Deaths 
at 40% coverage in the same year 
*Assumes DFID only supported additional services; †Refers to both met and unmet need 
‡Assumes DFID supported part of all services  
Create alternate family planning projections  
As described above, for each LiST analysis, multiple scenarios were created. The first (A, 
below) was the ‘with DFID support’ scenario. The second (D, below) was the ‘without DFID 
support’ scenario. Two additional scenarios not previously described were created (B and C, 
below) which were intended to strip out the impact of family planning and only calculate the 
impact of maternal and child health interventions. Scenario B modelled all of the health impacts 
that were in the ‘with DFID support’ scenario, but used the ‘without DFID support’ scenario for 
the family planning values. Scenario C, on the other hand, only included the ‘with DFID support’ 
family planning values and the ‘without DFID support’ maternal child health values. (Table 4) 
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Table 4. The LiST scenarios required for calculations for each analysis 
 DFID support for 
Family Planning 
Yes  No  
DFID Support 
for MNCH 
Yes A* B 
No C D‡ 
* A: ‘with DFID support’ scenario 
‡ D: ‘without DFID support’ scenario 
 
These four scenarios, described in table 4, were used to calculate the deaths averted 
due to DFID programming in three individual analyses. The first analysis modelled the total 
impact of both the MNCH programming and family planning (MNCH+FP). This was done by 
subtracting the total deaths observed in 2011–2015 in scenario A from those in scenario D for 
the same years (as described above). This was the primary result used for all of the maternal 
outcomes reported.  
Obtain MNCH results (for neonatal)  
The neonatal analysis was more complicated with respect to family planning. The UK 
Government target for newborn lives saved had been set on the basis of excluding the 
influence of family planning. Although family planning has a major influence on the number of 
newborn deaths at the epidemiological level, at the individual level we do not consider 
preventing a baby’s conception as saving its life. Regardless, knowing the total fertility rate was 
critical to understanding the number of births and thus the number of neonatal deaths. As a 
result, additional analyses were designed in which both the ‘with DIFD support’ and ‘without 
DFID support’ had identical family planning rates in order to eliminate the family planning 
impact. It would be impossible to accurately determine which set of family planning rates were 
more likely to be correct over the time period of the analysis. Thus the second analysis  of the 
three planned analyses looked at the impact of MNCH programming assuming that the 
contraceptive prevalence rate was the same as used in the scenario ‘without DFID support’. 
This was done by subtracting the total deaths in scenario B from those in Scenario D. The third 
and final analysis looked at the impact of MNCH programming assuming that the contraceptive 
prevalence rate was the same as in the scenario ‘with DFID support’. This was done by 
subtracting the total deaths in A from C. Since family planning programming data are integral in 
estimating the number of births, it was necessary to do two analyses to get the range of the 
likely change, given two different family planning scenarios. The range of results from the 2nd 
and 3rd analyses was reported as the primary result for the neonatal outcomes. For example, in 
one country, the total ‘lives saved’ from combining family planning increased from 16 to 28% 
with the health coverage increases, was 6,100.  If one considered two different, but equally 
plausible estimates of family planning coverage (1: unchanged with approximately 16% of 
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married women of reproductive age using family planning or 2: increased from 16% to 
approximately 28% of married women using family planning), then the ‘lives saved’ was either 
3,000 or 3,400.  The lower range was the result reported for this analysis. 
The primary result of the analysis was lives saved. That is, the number of deaths which 
are likely to not have occurred, at least partially because of DFID funding and inputs. In 
addition, we reported the deaths averted due to each health intervention within each country. 
The result of deaths averted does not take into consideration the fact that some of these 
children who are being saved due to one intervention can also die due to other causes at 
population risk. Thus, if one were to sum up the deaths averted by health interventions, this 
number will be slightly larger than the lives saved reported in the first analysis.  
 As many of the analyses were for multiple programs, or, inversely, multiple analyses 
were for one program, we chose not to report the deaths averted by individual program, but 
overall within the country.  
Although not integral to the results of this particular analysis, since they were available 
by default, we also reported the range of stillbirths averted and the range of deaths averted in 
children 1-59 months of age. 
Multi-country and multilateral programming  
The main LiST analysis methods described here are only relevant for the bilateral 
funding streams. Additional projects have been funded which are being implemented in 
multiple countries, such as Prevention of Maternal Death from Unwanted Pregnancy 
(PUMDUP), Evidence for Action (E4A) and Making it Happen (MiH). There is also support being 
given to multilateral organizations such as GAVI. Since it will be almost impossible to separate 
out the effects of bilateral programming from multilateral programming, it has been decided to 
not pursue these impacts at this time within this LiST analysis. In addition, there is currently 
relatively little programming which has the potential to have a notable impact on maternal or 
newborn mortality. 
Briefly though, the multi-country programming does have the ability to be analysed in 
certain situations. For each program with logframe data available, one question was asked: is 
there programming on the multi-country program topic from other programs in the same 
country which have already been included in the main LiST analysis. If the answer was no, then 
a new LiST analysis was done. In addition, if it could be determined that there was no 
programming on the multi-country program topic in a given calendar year, then the analysis 
was done only for those specific years. This second option required more forethought since 
many of the DFID programs actually reported non-calendar year results. This type of analysis 
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was tested starting in 2015 for the 2011–2013 results, with the intent to expand upon it in 
future years. Countries able to be included in the analysis are shown in Appendix A. 
Quality control methods 
The impact of this analysis is fully dependent on the results being credible, justifiable 
and reliable. This is a difficult task, given the reliance on secondary data collection from the 
DFID offices, and their reliance on selected data collection by either the country itself, or by the 
project implementers. Several steps were taken to mitigate the potential consequences of this 
reliance. First, any known additional data sources were included if needed, and general data 
quality checks were performed. Second, each country office was requested to validate their 
results. Third, alternate potential mortality rate data was used and presented for national 
analyses. Finally, two ranging analyses were designed to fit the analyses and reflect upon 
confidence in the resultant data.  
The Johns Hopkins staff assessed each reported potential indicator and intervention 
which was reported. If additional data sources were available and appropriate, they were 
compared to the reported data. If no baseline data were available from the DFID country office 
data collection template, these additional sources were used. In all cases, the DFID office was 
made aware of the additional data used, and then asked to confirm this new additional data. 
Other data quality checks were done, dependent on the exact data available. These included 
converting all services delivered values into coverage estimates based on the default Spectrum 
populations. If the values were not consistent with other available data, or suggested coverage 
of greater than 100%, then the DFID country office was asked to investigate.  
These data checks resulted in a series of direct questions which were posed to each of 
the DFID country offices. At that point, the country office was requested to validate or change 
the information which was prepared by the Johns Hopkins team within a short period. The 
responses from the DFID offices ranged from full acceptance of the results to disagreement 
with either some or all of the results. If possible, the comments from the country office were 
incorporated into the final results in the annual report. In situations where agreement or 
understanding could not be reached in a timely fashion, this was explicitly noted in the annual 
report. For example, Tanzania, in the second year of the analysis, felt that the family planning 
results were inappropriately high. This was noted and remedied in the third year of the analysis. 
Uncertainty 
In addition, it is clear that the results being reported in the primary analysis are subject 
to uncertainty. There is significant variability around several potential inputs to these analyses. 
For many of these it is impossible to determine the true confidence around the value, such as 
for number of ITNs delivered. Excluding those, several critical inputs of concern include the 
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mortality rates/ratios, the causes of death, the achieved/target values and the underlying 
population. In order to address these issues, several sensitivity analyses have been developed. 
The first is to rerun all of the analyses with alternate mortality rates. The standard mortality 
estimates used are from IGME(21). Alternate values could have been used from DHS/MICS 
surveys as well as IHME(23) or other local sources. As a result, the total results (number of 
deaths averted) could be very different. Each analysis was rerun with alternate values for the 
baseline mortality estimates, including IHME and DHS/MICS if there was a relatively recent 
(2008–2013) survey.  
An additional important estimate of uncertainty relates to target coverage values. In 
many cases, the program targets are the same as the national targets, without reference to 
their achievability. We modelled additional options, such as if only one half of the goal or ten 
percentage points more than the goal was achieved, to obtain a potential range around the 
estimates.  
It was anticipated that the underlying uncertainty within the Spectrum software will be 
able to be utilized for the 2014–15 round of analyses. This feature will include the ability to 
model uncertainty around the mortality rates, the coverage as reported by surveys, the cause 
of death structure and the effectiveness estimates.  
Ranging analyses 
Since it was not possible to calculate a true uncertainty estimate, two ranging analyses 
were created to generate a range of likely values that could be considered trustworthy around 
the maternal and neonatal deaths averted. The first simply asked whether or not the DFID 
country office had validated the results. If yes, then they were included as likely true results. 
The second asked about the quality and qualities of the data which was included. Only 
countries with multiple years of some achieved results and who had also checked their data 
were included in this analysis. In the early years of the project, relatively few countries were 
able to report actual data rather than forecast data, and thus, relatively few of the deaths 
averted were considered to have been achieved. By the third year of the analysis, the majority 
of countries were able to report at least some achieved results rather than forecasts.  
Limitations 
There are several limitations to this analysis that should be considered, many of which 
have already been mentioned. The types of limitations can be categorized three ways.  The first 
relates to data availability, the second is technical, related to the software itself, while the third 
is related to overall uses of modelled results.  
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Data Limitations 
Critical data elements for this analysis include both DFID-specific values as well as more 
general values. One important concern is that there is no good source for all of the 
achievements and targets which are being supported by DFID. The project monitoring systems 
do not necessarily include all critical activities; many only include a subset of activities and 
indicators. Thus it is likely that LiST is not modelling a comprehensive set of interventions for 
each program, and is underestimating the impacts of DFID programming. 
 Another concern surrounds the target values. In programs where the targets are 
delivery of specific interventions, it is relatively easy to estimate the outcomes and likely 
impacts. However, when the programming is distributed through third parties, national targets 
are often used. These are not necessarily based upon data, but upon the wishes of the national 
government. These become aspirational targets, rather than feasible and objective targets. As a 
result, LiST could be overestimating the potential future impacts. The second of the ranging 
analyses will hopefully take this into consideration, but it must still be considered in 
interpretation of the results. 
Just as critical as the DFID specific program inputs are several of the default values.  
Many are modelled results themselves, including the causes of death and the IGME mortality 
rates and ratios.  Plus, even though the newborn causes of death are available at the national 
level, the maternal causes of death are only available at regional levels. In addition, when 
extrapolating any of these values to the sub-regional areas for selected analysis, care must be 
taken.  Although a methodology exists for these extrapolations (22), the variability around them 
is uncertain. In addition, even when a program is modelled nationally, it may be implemented 
sub-nationally, and in select areas, resulting in additional and inestimable uncertainty.   
Technical Limitations 
LiST in itself has additional limitations, due to functionalities which do not (yet) exist.  
This may include interventions which have an impact on mortality, but are not currently 
available within LiST or Spectrum. One example is birth spacing (24, 25).  There is an impact on 
mortality, modulated through prematurity and small for gestational age, but at the time of the 
analysis in year 3, this feature was not 100% completed.  Thus, there are additional deaths 
which can be prevented, which have not been counted. In this case, this is likely to be a small 
effect, but when it is finally included, these deaths averted will be able to be combined with the 
effects of maternal and child health interventions.  Similar examples include the incomplete 
inclusion of hospital based care for newborns and for older children as well as for post-partum 
women. 
Also of consideration is the translation between behaviour change communication 
programming and the outcome, which is inadequately accounted for within LiST. For example a 
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hygiene program can educate on handwashing, but it is currently unclear how well that 
translates into handwashing behaviours. Currently, we are likely to be overestimating the 
impact by incorrectly assuming that all people who are educated practice the behaviour. We 
are also concerned about supply wastage.  For family planning supplies as well as other supply 
driven interventions (e.g., ITNs) we assume that all of the commodities are reaching their 
intended targets, although it is highly unlikely to be true. Thus, we believe that we are 
overestimating some of these impacts, but do not have a good estimate with which to modify 
this assumption. 
The effectiveness assumptions around the interventions are key components of the 
technical software description above.  Although these values are typically available in the peer 
reviewed literature, there are disagreements as to how appropriate each may be within a given 
context.  Thus future analyses incorporating the wide ranges of uncertainty around some of 
these values will be critical to improving the quality of the results for this, and all, LiST analyses. 
And finally, there are limitations around the assumptions relating to quality of care.  
Specifically during delivery care, there are standard algorithms which assume a specific quality 
relative to overall coverage levels.  Changes in quality were modelled by changing the 
proportion of interventions available; however, these are, as described above, assumptions.  
There is little objective evidence on how quality changes, which can have large effects on 
newborn and maternal mortality.  The impact of these changes on our estimations is unclear. 
Interpretation Limitations 
The use of modelling as a tool for monitoring and evaluation should also have its own 
serious caveats discussed. Models are simply that, they are models. They do not result in 
precise measurements of truth. They should not be used as stand-alone tools for assessing, 
program impact.  They should be considered as only one tool in the armament of those 
interested in truly understanding the ‘on-the-ground’ situation and how to best affect it.  
Additional and disparate information sources should always be considered; modelling results 
which are not plausible should be critically assessed to understand their implications. In the 
first round of analysis, undertaken in 2013, antenatal corticosteroids for premature delivery can 
be considered a useful example. Antenatal corticosteroids were one of the most critical 
interventions for reducing newborn mortality. However, this was not considered to be credible 
in the environments where these results were being modelled. Thus, the report included the 
result, with the assessment that the result was not credible. This combination of showing the 
modelled results in combination with a critical and informed interpretation is key for generating 
useful results for future discussion. This is necessary to justify the use of modelled results, 
rather than taking them at face value without that critical thinking. 
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There are many factors which may lead to these results either over- or under-estimating 
mortality, some of which have been discussed here. LiST will not, as no modelling tool can, 
solve all of the issues. The estimates of lives saved produced using this methodology are 
considered indicative of the underlying true values in the absence of being able to directly 
measure mortality changes as a result of DFID programming. Several uncertainty or ranging 
analyses help to pinpoint the true level, based upon the available data and knowledge of the 
communities of interest. 
As mentioned before, but which is also critical to remember is the distinction between 
attribution and contribution.  Although the analysis is often termed as an assessment of 
attribution, the authors consider it much more of a contribution analysis.  There are so many 
co-existing partners, projects, and trends related to health and as much, if not more, that are 
unrelated to health.  Thus DFID is both implicitly and explicitly working with all of these and all 
of its effects are intertwined with these external forces.  Nothing exists in a vacuum and the 
results of this analysis cannot adequately (or at all!) account for these forces. This fact must be 
considered in any presentation or use of the results: DFID contributes to saving lives in 
conjunction with all the known and unknown partners and changes.   
Discussion  
The results of this exercise should never be considered to be final exact results. There 
are many other factors in play which should be considered, but are not able to be fully 
mitigated.  As mentioned, there are several limitations to this analysis, including the modelling 
tool used, the data available to populate it, and the need for modelling and interpretation of 
modelling results.  Funding assumptions are critical – that is, that funding can directly be 
interpreted to relate to a change in coverage and mortality while not being aware of how 
others are acting in this environment.  There is no fool-proof way of mitigating this problem, so 
it must be discussed in every use of the results.  An additional consideration is in conflict 
situations or weak states. In these situations, the funding is often going to be used simply to 
maintain the current situation or prevent a more severe reduction in health status. In these 
situations, the use of funding to model impact may result in an overestimate of the additional 
lives saved, but may be a true reflection of the actual lives saved. 
Another consideration is that the results of this exercise are not directly comparable 
with results from other sources, such as global analyses or other donors. The specific 
methodology used is likely to be different. For example, in these analyses, family planning is 
assumed to have no impact on neonatal mortality, while others may choose to include that. In 
addition, different specific time frames analysed will also affect the level of lives saved. 
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The results of this project, as with any modelling activity or situation where the data are 
incomplete, have the ability to be misused. The results, in terms of lives saved, could be 
published and used to indicate that some programs are inefficient, but that is not appropriate 
since in this exercise, we are not considering contextual factors such as civil strife, natural 
disasters, political changes and cultural history, which are all important to consider. These 
results are being calculated to support the framework for results, and will only be published in 
aggregate form to indicate how many lives saved it is likely that DFID has contributed to. We 
deliberately use the terminology ‘contributed to’ in all project documents, and in all reports 
referring to this project. In addition, the framework for results only includes maternal and 
newborn mortality: many of the projects being analysed will also have an impact on stillbirths 
or children 1-59 months of age. Thus the reported lives saved cannot be the total impact of the 
programming. This project was designed with the express purpose of measuring and evaluating 
the impact of DFID health programming on maternal and newborn mortality. A methodology 
was developed to attempt to reach that goal.  As of now, LiST is an adequate piece of software 
which has the flexibility to respond to DFID’s queries. It is hoped that as the end of the project 
approaches, the observed increase in data availability as well as improvements in the software 
will continue to meet the needs of DFID. 
References 
1.  DFID. Choices for women: planned pregnancies, safe births and healthy newborns. The UK’s 
Framework for Results for improving reproductive, maternal and newborn health in the 
developing world. 2010; Available from: www.gov.uk/government/publications/choices-for-
women-planned-pregnancies-safe-births-and-healthy-newborns     
2.   CHERG. Available from: www.livessavedtool.org. 
3.  UNICEF. Available from: http://www.devinfolive.info/mbb/mbbsupport/. 
4.  Avenir Health. Available from: http://www.avenirhealth.org/software-onehealth.php. 
5.  Marie Stopes International. Available from: http://mariestopes.org/impact-2. 
6.  RTI. Available from: http://mnhtech.org/. 
7.  Walker N, Tam Y, Friberg IK. Overview of the Lives Saved Tool (LiST). BMC public health. 
2013;13 Suppl 3:S1. Epub 2014/02/26. 
8.  Avenir Health. Spectrum. http://www.avenirhealth.org/software-spectrum  
9.  Stover J, McKinnon R, Winfrey B. Spectrum: a model platform for linking maternal and child 
survival interventions with AIDS, family planning and demographic projections. International 
journal of epidemiology. 2010;39 Suppl 1:i7-10. Epub 2010/04/02. 
10.  Boschi-Pinto C, Young M, Black RE. The Child Health Epidemiology Reference Group reviews 
of the effectiveness of interventions to reduce maternal, neonatal and child mortality. 
International journal of epidemiology. 2010;39 Suppl 1:i3-6. Epub 2010/04/02. 
11.  Black RE, Morris SS, Bryce J. Where and why are 10 million children dying every year? 
Lancet. 2003;361(9376):2226-34. Epub 2003/07/05. 
 Page | 26 
 
12.  Jones G, Steketee RW, Black RE, Bhutta ZA, Morris SS, Bellagio Child Survival Study G. How 
many child deaths can we prevent this year? Lancet. 2003;362(9377):65-71. Epub 2003/07/11. 
13.  Lawn JE, Cousens S, Zupan J, Lancet Neonatal Survival Steering T. 4 million neonatal deaths: 
when? Where? Why? Lancet. 2005;365(9462):891-900. Epub 2005/03/09. 
14.  Lawn JE, Blencowe H, Oza S, You D, Lee AC, Waiswa P, et al. Every Newborn: progress, 
priorities, and potential beyond survival. Lancet. 2014;384(9938):189-205. Epub 2014/05/24. 
15.  Bhutta ZA, Ahmed T, Black RE, Cousens S, Dewey K, Giugliani E, et al. What works? 
Interventions for maternal and child undernutrition and survival. Lancet. 2008;371(9610):417-
40. Epub 2008/01/22. 
16.  Bhutta ZA, Das JK, Rizvi A, Gaffey MF, Walker N, Horton S, et al. Evidence-based 
interventions for improvement of maternal and child nutrition: what can be done and at what 
cost? Lancet. 2013;382(9890):452-77. Epub 2013/06/12. 
17.  Pattinson R, Kerber K, Buchmann E, Friberg IK, Belizan M, Lansky S, et al. Stillbirths: how 
can health systems deliver for mothers and babies? Lancet. 2011;377(9777):1610-23. Epub 
2011/04/19. 
18.  Bhutta ZA, Yakoob MY, Lawn JE, Rizvi A, Friberg IK, Weissman E, et al. Stillbirths: what 
difference can we make and at what cost? Lancet. 2011;377(9776):1523-38. Epub 2011/04/19. 
19.  Winfrey W, McKinnon R, Stover J. Methods used in the Lives Saved Tool (LiST). BMC public 
health. 2011;11 Suppl 3:S32. Epub 2011/04/29. 
20.  Yukich J, Bennett A, Keating J, Yukich RK, Lynch M, Eisele TP, et al. Planning long lasting 
insecticide treated net campaigns: should households' existing nets be taken into account? 
Parasites & vectors. 2013;6:174. Epub 2013/06/15. 
21.  WHO and UNICEF. Available from: childmortality.org. 
22.  Amouzou A, Richard SA, Friberg IK, Bryce J, Baqui AH, El Arifeen S, et al. How well does LiST 
capture mortality by wealth quintile? A comparison of measured versus modelled mortality 
rates among children under-five in Bangladesh. International journal of epidemiology. 2010;39 
Suppl 1:i186-92. Epub 2010/04/02. 
23.  Wang H, Liddell CA, Coates MM, Mooney MD, Levitz CE, Schumacher AE, et al. Global, 
regional, and national levels of neonatal, infant, and under-5 mortality during 1990 – 2013: a 
systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9947):957-
79. Epub 2014/05/07. 
24.  Kozuki N, Sonneveldt E, Walker N. Residual confounding explains the association between 
high parity and child mortality. BMC public health. 2013;13 Suppl 3:S5. Epub 2014/02/26. 
25.  Kozuki N, Walker N. Exploring the association between short/long preceding birth intervals 
and child mortality: using reference birth interval children of the same mother as comparison. 
BMC public health. 2013;13 Suppl 3:S6. Epub 2014/02/26. 
Acknowledgements 
Production of this technical note was funded by the UK government. Thanks to Gillian 
Mann (senior health adviser, DFID) for helpful comments on several drafts of this document. 
Thank you also to the external peer reviewers for their helpful and insightful comments. 
 Page | 27 
 
Appendices 
These appendices (A and B) are designed to be updated annually as a new round of 
analyses is completed. There is a space for results in 2017 for completeness even though this 
has not yet been funded. 
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Appendix A: DFID focus Countries analysed 
 
Table A. List of DFID focus countries included in the final analysis, by year in which the results 
were reported.  
 Year reported 2013 2014 2015 2016 2017* 
 Years 
analysed 
2011 
2011–
2012 
2011–
2013  
2011–
2014  
2011–
2015  
Region Country      
Africa 
Burundi      
DRC**  X X X  
Ethiopia X X X X  
Ghana X X X X  
Kenya X X X X  
Liberia   X X  
Malawi X X X X  
Mozambique X X X X  
Nigeria X X X X  
Rwanda X X‡ X‡ X‡  
Sierra Leone X X X X  
Somalia X X X X  
South Africa    X  
South Sudan   X X  
Sudan      
Tanzania X X X X  
Uganda X X X X  
Zambia X X X X  
Zimbabwe X  X X  
ASCOT 
Bangladesh X X X X  
Burma X X X, M X  
India X X X X  
Indonesia      
Nepal X X X X  
Vietnam      
Western 
Asia 
Afghanistan   M   
Central Asia   X X  
Pakistan X X X X  
Regional Yemen X X X X  
Total - 19 19† 23   
X: included in main analysis; M: included in multi-country analysis; *Will be updated when 
analysis is performed; **Democratic Republic of Congo; †South Africa also reported, but was 
unable to be analysed; ‡All data analysed was reported in the first year of the analysis.  
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Appendix B: Spectrum software 
Each year a new and updated version of the Spectrum software is used to complete the 
analyses. The shift from version 4.x to 5.x is a large difference with notable changes in 
population structure and technical inputs. The differences noted within primary version 
numbers is typically not as pronounced as between version numbers. The intention is that the 
version used will be a publically available version, but it will also balance the need for having 
the most up-to-date data and format as well as the need for corrections to known errors. In the 
first two years of the analysis, it was possible to use a publically available version of the 
software. However, in the 3rd year, it was not possible to wait for the version to be released to 
complete the analysis. For more information on the current LiST version and software available, 
please visit the official website, livessavedtool.org. 
2010–2011 results (reported in 2013): Spectrum 4.58 
2010–2012 results (reported in 2014): Spectrum 4.71 
2010–2013 results (reported in 2015): Spectrum 5.2 beta 12 
2010–2014 results (reported in 2016): Spectrum 5.33 
2010–2015 results (reported in 2017): 
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Appendix C: Interventions – for Spectrum version 5.31 
This table lists all of the interventions which can be modelled by the Spectrum software, 
at the time this method note was finalized.  For each link between an intervention and a type of 
death (maternal, neonatal, stillbirth and child) there is an effect size and a cause of death. It is 
possible for some of these values and linkages to change as frequently as every year.  Some 
interventions have direct effects on mortality, while others work via changing risk factors, such 
as stunting, wasting or disease incidence.  For the full details on how each intervention works, 
please see the help menus within the publically available version of the software, available at 
livessavedtool.org. This table does not list interventions modelled by either the HIV module 
(AIM) or the family planning module (FamPlan). Also note that the terminology in this table 
matches the LiST terminology and may not match the exact terminology used by specific 
interventions within the DFID system.  Interventions were matched to project activities based 
on an understanding of the content, not the specific label. 
Interventions 
Periconceptual  Immunizations 
Folic acid supplementation/fortification DPT 
Safe abortion services H. influenzae b 
Post abortion case management HepB 
Ectopic pregnancy case management Pneumococcal 
Antenatal Rotavirus 
TT - Tetanus toxoid vaccination Measles 
IPTp - Pregnant women protected via 
intermittent preventive treatment of malaria 
during pregnancy or by sleeping under an ITN 
Postnatal through 5 years of age - 
Curative 
Syphilis detection and treatment Maternal Sepsis case management 
Calcium supplementation Case management of premature babies 
Micronutrient supplementation (multiple 
micronutrients + iron folate) Thermal care 
Iron supplementation KMC - Kangaroo mother care 
Multiple micronutrient supplementation Full supportive care for prematurity 
Balanced energy supplementation Case management of severe neonatal infection 
Hypertensive disorder case management Oral antibiotics 
Diabetes case management Injectable antibiotics 
Malaria case management Full supportive care for sepsis/pneumonia 
MgSO4 - Management of pre-eclampsia ORS - oral rehydration solution 
FGR - Fetal growth restriction detection and 
management Antibiotics - for treatment of dysentery 
Delivery care Zinc - for treatment of diarrhoea 
Clean birth practices Oral antibiotics for pneumonia 
Immediate assessment and stimulation Vitamin A - for treatment of measles 
Labour and delivery management 
Antimalarials - Artemesinin compounds for 
malaria 
Neonatal resuscitation Therapeutic feeding - for severe wasting 
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Antenatal corticosteroids for preterm labour Treatment for moderate acute malnutrition 
Antibiotics for pPRoM  
MgSO4 management of eclampsia  
AMTSL--active management of the third stage 
of labour 
 
Induction of labour for pregnancies lasting 41+ 
weeks 
 
Postnatal through 5 years of age - 
Preventive 
 
Breastfeeding  
Clean postnatal practices  
Chlorhexidine  
Complementary feeding--education only  
Complementary feeding--supplementation and 
education 
 
Vitamin A supplementation  
Zinc supplementation  
Improved water source  
Water connection in the home  
Improved sanitation - Utilization of latrines or 
toilets 
 
Hand washing with soap  
Hygienic disposal of children's stools  
ITN/IRS  -  Ownership of insecticide treated 
nets (ITN/LLIN) or household protected with 
indoor residual spraying 
 
 
 
 
 
